Caring Brands (CABR) EBT Margin (2024 - 2025)
Caring Brands (CABR) posted quarterly EBT Margin of 235565.57% for Q4 2025, down 5001912.0% year-over-year from N/an in Q4 2024, and down 5.87% quarter-over-quarter from 222500.54% in Q3 2025.
Caring Brands (CABR) EBT Margin (2024 - 2025) Analysis & Trends
Caring Brands' EBT Margin history runs 2 years deep, the most recent figure standing at 235565.57% for Q4 2025.
- In Q4 2025, EBT Margin fell 5001912.0% year-over-year to 235565.57%; the TTM figure through Dec 2025 stood at 159275.47% (changed N/A YoY), while the FY2025 annual figure was 176385.98%, changed N/A from the prior year.
- EBT Margin for Q4 2025 stood at 235565.57%, down from 222500.54% in the prior quarter.
- The five-year high for EBT Margin was 36744.04% in Q1 2025, with the low at 235565.57% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Caring Brands | 12.14 Mn | 10.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -235,565.57% |
| Sep 30, 2025 | -222,500.54% |
| Mar 31, 2025 | -36,744.04% |
| Dec 31, 2024 | -185,546.45% |